Protagen will use its UNIarray technology to identify autoantibody biomarkers in patients enrolled in SuppreMol's ongoing Phase IIa trial of SM101 to treat systemic lupus erythematosus (SLE)

Protagen AG

Germany / Tools, Services, and Manufacturing

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

SuppreMol GmbH

Germany / Private Biopharma

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced